Fritextsökning
Innehållstyper
-
De förlänger läkemedels livslängd
I samarbete med Affibody har KTH-forskarna Torbjörn Gräslund och Johan Seijsing utvecklat en ny teknik för att förlänga halveringstiden för proteinläkemedel.
-
Changeable proteins cause nerve disease
An incorrectly folded protein is one of the reasons behind the nerve disease ALS, according to new research. But the protein does not have structural errors all...
-
De tar plats på IVA
Getinges före detta vd Johan Malmquist, Linköpings universitets rektor Helen Dannetun och Metabogen-grundaren Fredrik Bäckhed är tre av 15 nya ledamöter på IVA.
-
Wallenbergmiljard till unga forskare
Satsar 1,2 miljarder kronor på forskning.
-
Satsar på köp
”Vi riktar in oss på bolag inom speciella nischer där det finns spetskompetens”, säger Kristina Willgård, vd på Addtechs nybildade life science-bolag Addlife.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Definite answer with new cancerous gene
A newly discovered cancer gene is enabling the diagnosis of adenoid cystic caranoima using a genetic test.
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Svenskar leder internationellt slag mot influensa
EU satsar 53 miljoner kronor på ett internationellt influensaprojekt där de svenska bioteknikföretagen Vironova och Beactica deltar.
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
Hallå där, Leif Andersson ...
...professor i funktionsgenomik vid Uppsala universitet som valts in i National Academy of Sciences, Nas, en tung opinionsbildare inom forskningspolitik i USA. ...
-
Han ska leda MRA
Det nystartade initiativet Medical Research Academy, MRA, har fått en ledare i dansken Flemming Steen Jørgensen.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Discovery of new role for leukemia gene
Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell d...
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Metabolic pro heads prefect post
The dean of the Department of Biomedicine at the Sahlgrenska Academy has appointed a new assistant prefect.
-
KI-profil får IVAs guldmedalj
Professor Hans Wigzell belönas med Kungl. Ingenjörsvetenskapsakademien, IVAs, guldmedalj för sitt engagemang för kommersialisering av bioteknikforskning. Tack v...
-
Life science management for hire
Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and...
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Många resultat inom cancerforskningen håller inte
Ny genomgång visar att många publicerade resultat inte kan upprepas.
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
BREAKING